01 1Teva Pharmaceutical Industries
01 1TRILACICLIB
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-10-24
Pay. Date : 2024-08-07
DMF Number : 40179
Submission : 2024-09-05
Status : Active
Type : II
20
Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRILACICLIB, with a corresponding US DMF Number 40179.
Remarkably, this DMF maintains an Active status since its submission on September 05, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2024, and payment made on August 07, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
